Catalyst Wire Dossier Catalyst Wire Dossier

House Dust Mite Allergoid

house dust mite allergoid extract · Allergopharma GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for House Dust Mite Allergoid, covering 2013-02-11 to 2015-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma [Phase 3]

See pricing